Table 1.

Effects of anti-PSGL-1 antibodies, P-selectin-IgG chimera, and anti-L-selectin antibody on lymphocyte adherence to KG1a cells

Blocking treatmentsPercentage control binding* (SEM)
Anti–PSGL-1 monoclonal antibodies (20 μg/mL of each in a cocktail) 103.0 (7.0)  
P-selectin–IgG chimera, 50 μg/mL 97.6 (7.4)  
Anti–L-selectin antibody 1.9 (0.6) 
Blocking treatmentsPercentage control binding* (SEM)
Anti–PSGL-1 monoclonal antibodies (20 μg/mL of each in a cocktail) 103.0 (7.0)  
P-selectin–IgG chimera, 50 μg/mL 97.6 (7.4)  
Anti–L-selectin antibody 1.9 (0.6) 
*

Number of lymphocytes adherent to confluent area of KG1a were counted by light microscopy using an ocular grid under 100× magnification (quantified a minimum of 3 fields per slide, 3 slides per experiment, 3 separate experiments). Results are presented as percentage binding compared with corresponding isotype MoAb-treated control KG1a cytospin preparations.

Similar abrogation of binding was observed in assays performed in the presence of EDTA and utilizing PMA-treated lymphocytes (see text for details).

Close Modal

or Create an Account

Close Modal
Close Modal